Dr. L H Hiranandani Hospital and International Oncology Services organized ‘The Pink Meet – 2014’, a comprehensive conference to discuss new medical insights on breast cancer, in Mumbai on February 1 and 2 in which over 150 doctors from across the country assembled to share their latest experiences and knowledge for breast cancer care and treatment.
The social impact of breast cancer was also discussed in this two-day comprehensive breast cancer care conference with topics such as “Fertility beyond breast cancer.” Niranjan Hiranandani, Chief Managing Trustee of Dr. L H Hiranandani Hospital inaugurated the conference.
Leading cancer specialists including Dr. Rajendra Badwe, Dr. Suresh Advani, Dr. Rajiv Sarin, IVF specialist, Dr. Anirudhha Malpani and nuclear medicine expert Dr. Vikram Lele shared their insights and experiences on the new practices in diagnoses, treatment and care for breast cancer including genetics of the disease, breast reconstruction post treatment, role of nuclear medicine in early diagnosis, etc.
Oncology experts from Dr. L H Hiranandani Hospital, including Dr. Namita Pandey, Dr. Prasad Raj Dandekar and Dr. Wasim Phoplunkar were also present at the event this year.
Dr. Sujit Chatterjee, CEO, Dr. L H Hiranandani hospital and also the Chief coordinator of ‘The Pink Meet – 2014’ stated, “Realizing the need for medical community’s engagement in the fight against breast cancer, Dr. L H Hiranandani Hospital along with International Oncology started ‘The Pink Meet’: a medical conference with social relevance. The conference today has moved beyond deliberating the scientific aspects of breast cancer and also discusses the social impact; such as issues of fertility after cancer treatment. We are proud to provide the experts in the field a platform yet again to interact with the fraternity and discuss their experiences.”
The coordinator for the event, Dr. Neeraj Mehta, & Regional Head – International Oncology Services Pvt. Ltd., said, “With ‘The Pink Meet,’ we are trying to provide tremendous support and hope and information to help the patients (women). On such a wide platform doctors can come and share knowledge about the medical advances made in the field of breast oncology and their experiences. This would help them render the best possible treatment to their patients.”
Source : PharmaBiz